Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register

BACKGROUND: There are limited data regarding efficacy of abatacept treatment for rheumatoid arthritis (RA) outside clinical trials. Quality registers have been useful for observational studies on tumor necrosis factor inhibition in clinical practice. The aim of this study was to investigate clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagnotto, Giovanni, Willim, Minna, Nilsson, Jan-Åke, Compagno, Michele, Jacobsson, Lennart T. H., Saevarsdottir, Saedis, Turesson, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977240/
https://www.ncbi.nlm.nih.gov/pubmed/31969172
http://dx.doi.org/10.1186/s13075-020-2100-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977240/
https://www.ncbi.nlm.nih.gov/pubmed/31969172
http://dx.doi.org/10.1186/s13075-020-2100-y

Ejemplares similares